USPTO serial 79448221
UVENCE
Reviewed by CopyMark Law Group
Status 641Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- WOLFSEN, CHRISTIANNE LISBETH
- Law office
- TMO LAW OFFICE 129
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with UVENCE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical and medicinal preparations, namely, pharmaceutical and medicinal extracts in the nature of human adipose tissue extracts for subsequent subcutaneous injection on intact or scarred skin; products for aesthetic medical applications, namely, injectable skin rejuvenation products, injectable preparations containing human adipose tissue; injectable nano fat preparations for skin rejuvenation; reconstituted cells for medical treatments for skin care; reconstituted cells for clinical treatments for skin care; autologous fat preparations for medical purposes; skin hydrators being injectable dermal fillers; pharmaceutical preparations for cellular therapy for the treatment of skin wrinkles, skin elasticity and scarring; injectable fillers for medical aesthetic use; injectable dermal fillers; fat cells for clinical treatment for skin care; collagen for medical purposes; fillers comprised of living tissues; medicated skin care preparations; medicinal creams for the protection of the skin; pharmaceutical preparations for treating skin disorders; syringes sold filled with injectable stem cell dermal fillers; gels, creams and solutions for dermatological use. | ACTIVE | — |
| 010 | Apparatus and instruments for injecting pharmaceutical preparations; injectors for medical purposes; syringes for injections; hypodermic syringes; medical apparatus for introducing pharmaceutical preparations and fats cells into the human body; skin regeneration therapy apparatus; medical apparatus for injecting fillers; skin moisture analysers for medical purposes. | ACTIVE | — |
| 044 | Medical services relating to the removal, treatment and processing of nano fat and stem cells; medical services, namely harvesting adipose tissue and utilising such tissue for medical purposes such as regenerative treatment; medical clinic services; medical and aesthetic surgery services; aesthetic medicine services; facial rejuvenation services using injectable fillers; cosmetic treatment services; providing medical aesthetic procedures, namely, treating the skin with dermal fillers; aesthetic medicine services, namely, liposuction treatment, injectable filler treatments and skin care services. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 6, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 23, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 23, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 5, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 4, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 2, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 23, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 23, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 16, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |